Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sm14 vaccine with GLA-SE in adults in schistosomiasis endemic regions
NCT03041766Phase 2Completed
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Dec 2016
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Sm14 in schistosomiasis, sponsored by Fundação Oswaldo Cruz. Primary endpoint: Number of Participants with Adverse Events. Started Dec 2016; status: completed.
02
Drugs
Sm14
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT03041766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03041766.